We are live on ! Find out more
TNYA icon

Tenaya Therapeutics

47 hedge funds and large institutions have $668M invested in Tenaya Therapeutics in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 2

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3.64% more ownership

Funds ownership: 82%85.65% (+3.6%)

0% more funds holding

Funds holding: 4747 (0)

4% less capital invested

Capital invested by funds: $693M → $668M (-$25.8M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
47
Holders Change
Holders Change %
0%
% of All Funds
0.72%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
8
Increased
22
Reduced
2
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
51
SG Americas Securities
New York
-$129K -6,237 Closed
PCM
52
Pinz Capital Management
New York
-$52K -2,508 Closed
CAPTRUST Financial Advisors
53
CAPTRUST Financial Advisors
North Carolina
-$1K -26 Closed
Osaic Holdings
54
Osaic Holdings
Arizona
+$567 +26 New

TNYA Hedge Fund Activity: Q4 2021 in Review

47 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q4 2021, worth a combined $668M — down 3.7% from $693M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TNYA positions and 7 closed out — a net gain of 1 holder — while 22 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $13.5M. The largest seller was Woodline Partners, exiting entirely with an estimated $3.1M sold.

  • 47 institutional investors held Tenaya Therapeutics (TNYA) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $668M of Tenaya Therapeutics stock for Q4 2021, down 3.7% quarter-over-quarter.
  • 8 funds opened new Tenaya Therapeutics positions in Q4 2021 and 7 closed out, a net change of +1 holder.
  • The largest Tenaya Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $13.5M added.
  • The largest Tenaya Therapeutics seller in Q4 2021 was Woodline Partners, an estimated $3.1M sold.

Based on aggregated 13F filings for Q4 2021.